WallStreetZenWallStreetZen

NASDAQ: ANTX
An2 Therapeutics Inc Stock Forecast, Predictions & Price Target

Analyst price target for ANTX

Based on 2 analysts offering 12 month price targets for An2 Therapeutics Inc.
Min Forecast
$7.00+115.38%
Avg Forecast
$18.50+469.23%
Max Forecast
$30.00+823.08%

Should I buy or sell ANTX stock?

Based on 2 analysts offering ratings for An2 Therapeutics Inc.
Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 50%
Hold
1 analysts 50%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their ANTX stock forecasts and price targets.

ANTX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-02-13
lockedlocked$00.00+00.00%2024-01-04

1 of 1

Forecast return on equity

Is ANTX forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
37.27%

Forecast return on assets

Is ANTX forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

ANTX revenue forecast

What is ANTX's revenue in the next 2 years based on estimates from 1 analyst?
Avg 1 year Forecast
$72.7M
Avg 2 year Forecast
$217.0M

ANTX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ANTX$3.25$18.50+469.23%Buy
CNTB$1.74$7.00+302.30%Buy
CVM$1.91N/AN/A
MIST$1.79$15.00+737.99%Strong Buy
CMRX$1.06$11.00+937.74%Buy

An2 Therapeutics Stock Forecast FAQ

Is An2 Therapeutics Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: ANTX) stock is to Buy ANTX stock.

Out of 2 analysts, 0 (0%) are recommending ANTX as a Strong Buy, 1 (50%) are recommending ANTX as a Buy, 1 (50%) are recommending ANTX as a Hold, 0 (0%) are recommending ANTX as a Sell, and 0 (0%) are recommending ANTX as a Strong Sell.

If you're new to stock investing, here's how to buy An2 Therapeutics stock.

What is ANTX's revenue growth forecast for 2026-2027?

(NASDAQ: ANTX) An2 Therapeutics's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 39.22%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.52%.

An2 Therapeutics's revenue in 2024 is $0.On average, 1 Wall Street analysts forecast ANTX's revenue for 2026 to be $2,162,203,052, with the lowest ANTX revenue forecast at $2,162,203,052, and the highest ANTX revenue forecast at $2,162,203,052.

In 2027, ANTX is forecast to generate $6,453,893,565 in revenue, with the lowest revenue forecast at $6,453,893,565 and the highest revenue forecast at $6,453,893,565.

What is ANTX's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: ANTX) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is ANTX's Price Target?

According to 2 Wall Street analysts that have issued a 1 year ANTX price target, the average ANTX price target is $18.50, with the highest ANTX stock price forecast at $30.00 and the lowest ANTX stock price forecast at $7.00.

On average, Wall Street analysts predict that An2 Therapeutics's share price could reach $18.50 by Feb 13, 2025. The average An2 Therapeutics stock price prediction forecasts a potential upside of 469.23% from the current ANTX share price of $3.25.

What is ANTX's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: ANTX) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.